BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28060748)

  • 1. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
    Choi JP; Kim SJ; Park IJ; Hong SM; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JB; Yu CS; Kim JC
    Oncotarget; 2017 Feb; 8(6):10375-10384. PubMed ID: 28060748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Responsiveness of Lymph Nodes to Preoperative Chemoradiotherapy in Patients With Rectal Cancer on Prognosis After Radical Resection.
    Lee HG; Kim SJ; Park IJ; Hong SM; Lim SB; Lee JB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e191-e199. PubMed ID: 31014994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
    Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
    World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
    Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph nodes regression grade is a predictive marker for rectal cancer after neoadjuvant therapy and radical surgery.
    Li J; Yuan J; Liu H; Yin J; Liu S; Du F; Hu J; Li C; Niu X; Lv B; Xing S
    Oncotarget; 2016 Mar; 7(13):16975-84. PubMed ID: 26934651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the pathological response of the mesorectal positive nodes between short-course chemoradiotherapy with delayed surgery and long-course chemoradiotherapy in patients with rectal cancer.
    Beppu N; Kobayashi M; Matsubara N; Noda M; Yamano T; Doi H; Kamikonya N; Kakuno A; Kimura F; Yamanaka N; Yanagi H; Tomita N
    Int J Colorectal Dis; 2015 Oct; 30(10):1339-47. PubMed ID: 26206348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
    Fokas E; Liersch T; Fietkau R; Hohenberger W; Beissbarth T; Hess C; Becker H; Ghadimi M; Mrak K; Merkel S; Raab HR; Sauer R; Wittekind C; Rödel C
    J Clin Oncol; 2014 May; 32(15):1554-62. PubMed ID: 24752056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
    Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
    Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
    Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
    Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
    PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Extranodal Extension in Rectal Cancer Patients Undergoing Radical Resection After Preoperative Chemoradiotherapy.
    Kim YI; Cho H; Kim CW; Park Y; Kim J; Ro JS; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2021 Mar; 20(1):e35-e42. PubMed ID: 33191166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic evaluation of the response of mesorectal positive nodes to preoperative chemoradiotherapy in patients with rectal cancer.
    Beppu N; Matsubara N; Noda M; Yamano T; Kakuno A; Doi H; Kamikonya N; Yamanaka N; Yanagi H; Tomita N
    Surgery; 2015 Apr; 157(4):743-51. PubMed ID: 25724092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Relevance of Lymph Node Regression After Neoadjuvant Chemoradiation for Esophageal Cancer.
    Philippron A; Bollschweiler E; Kunikata A; Plum P; Schmidt C; Favi F; Drebber U; Hölscher AH
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):549-558. PubMed ID: 28043475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients.
    Jung JH; An HJ; Kim HJ; Lee J; Lee KM; Kim SH; Cho HM; Shim BY
    Korean J Intern Med; 2016 Jan; 31(1):134-44. PubMed ID: 26767867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the relationship between tumor regression grade and lymph node regression grade].
    Zhao Q; Fu C; Yu E; Zhang W; Meng R; Wang H; Hao L; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1050-1054. PubMed ID: 28900999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.
    Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P
    J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer.
    Han J; Noh GT; Yeo SA; Cheong C; Cho MS; Hur H; Min BS; Lee KY; Kim NK
    Medicine (Baltimore); 2016 Sep; 95(38):e4891. PubMed ID: 27661032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
    Kim SH; Chang HJ; Kim DY; Park JW; Baek JY; Kim SY; Park SC; Oh JH; Yu A; Nam BH
    Cancer Res Treat; 2016 Jul; 48(3):998-1009. PubMed ID: 26511803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.